Cite

HARVARD Citation

    Harjunpää, H. et al. (2018). Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis. Oncoimmunology. p. . [Online]. 
  
Back to record